Neuropsycholgy and Neuroimaging in Transient Global Amnesia

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02562560

Acronym

2NIA

Enrollment

Registered

2015-09-29

Start date

2008-09-30

Completion date

2015-12-31

Last updated

2020-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient Global Amnesia (TGA)

Brief summary

The purpose of this study is to establish a diagnosis in transient global amnesia (TGA) in assessing three episodic memory's abilities (mental simulation throught the future, and the past, the learning of personnal actions i-e the enactment effect). Secondary goal is to describe the neuronal substrates associated to the alteration of theses abilites in TGA.

Interventions

BEHAVIORALNeuropsychological tests

DEVICECerebral imaging (MRI, PET-FDG)

Study design

Primary purpose

DIAGNOSTIC

Eligibility

Sex/Gender

ALL

Age

30 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* All the participants * Minimum of 7 years of education * French native speaker * Healthy subjects : Non pathological Dementia rating scale score * Patients : Clinical diagnosis of TGA according to Hodges and Warlow's criterion

Exclusion criteria

* Chronic neurological disease * Encephalitis * Endocrinal disease * Hepatic disease * Case history of head injury with loss of consciousness of more than one hour * Case history of stroke * Case history of cancer during the five last years except squamous cell carcinomas * Alcoholism or drug addiction * Major psychiatric disorders according the Diagnostic and Statistical Manual of -Mental Disorders

Design outcomes

Primary

Measure	Time frame
Episodic memory scores	3 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026